Cargando…

Combination of Polymeric Micelle Formulation of TGFβ Receptor Inhibitors and Paclitaxel Produce Consistent Response Across Different Mouse Models of TNBC

Triple-negative breast cancer (TNBC) is notoriously difficult to treat due to the lack of targetable receptors and sometimes poor response to chemotherapy. The transforming growth factor-beta (TGFβ) family of proteins and their receptors (TGFR) are highly expressed in TNBC and implicated in chemothe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vinod, Natasha, Hwang, Duhyeong, Fussell, Sloane Christian, Owens, Tyler Cannon, Tofade, Olaoluwa Christopher, Copling, Sage, Ramsey, Jacob D., Rädler, Patrick D., Atkins, Hannah M., Livingston, Eric E., Ezzell, J. Ashley, Sokolsky-Papkov, Marina, Yuan, Hong, Perou, Charles M., Kabanov, Alexander V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312717/ https://www.ncbi.nlm.nih.gov/pubmed/37398150 http://dx.doi.org/10.1101/2023.06.14.544381

Ejemplares similares

Cheminformatics-driven discovery of polymeric micelle formulations for poorly soluble drugs
por: Alves, Vinicius M., et al.
Publicado: (2019)

High-capacity poly(2-oxazoline) formulation of TLR 7/8 agonist extends survival in a chemo-insensitive, metastatic model of lung adenocarcinoma
por: Vinod, Natasha, et al.
Publicado: (2020)

Drug-Dependent Morphological Transitions in Spherical and Worm-Like Polymeric Micelles Define Stability and Pharmacological Performance of Micellar Drugs
por: Lim, Chaemin, et al.
Publicado: (2022)

Synthesis of Well-Defined Gold Nanoparticles Using Pluronic: The Role of Radicals and Surfactants in Nanoparticles Formation
por: Sokolsky-Papkov, Marina, et al.
Publicado: (2019)

Enhancing CDK4/6 inhibitor therapy for medulloblastoma using nanoparticle delivery and scRNA-seq–guided combination with sapanisertib
por: Lim, Chaemin, et al.
Publicado: (2022)

MEDB-56. POx NPs mediated delivery of (TLR7/8) agonist resiquimod improves treatment outcomes in SHH medulloblastoma by targeting tumor associated macrophages
por: Hwang, Duhyeong, et al.
Publicado: (2022)

Digital necrosis following combined liquid nitrogen and candida antigen therapy for digital warts
por: Copling, Sage, et al.
Publicado: (2023)

Controlling Kinetic Pathways in Demixing Microgel–Micelle Mixtures
por: Fussell, S. L., et al.
Publicado: (2023)

Inhibition of UCH-L1 Deubiquitinating Activity with Two Forms of LDN-57444 Has Anti-Invasive Effects in Metastatic Carcinoma Cells
por: Kobayashi, Eiji, et al.
Publicado: (2019)

Pre-treatment with the CDK4/6 inhibitor palbociclib improves the efficacy of paclitaxel in TNBC cells
por: Cretella, Daniele, et al.
Publicado: (2019)

1-Chromonyl-5-Imidazolylpentadienone Demonstrates Anti-Cancer Action against TNBC and Exhibits Synergism with Paclitaxel
por: Modi, Karan, et al.
Publicado: (2020)

Ginsenoside panaxatriol reverses TNBC paclitaxel resistance by inhibiting the IRAK1/NF-κB and ERK pathways
por: Wang, Panpan, et al.
Publicado: (2020)

Chemotherapy with ceramide in TNBC
por: Legembre, Patrick, et al.
Publicado: (2015)

GHRH-antagonists in TNBC
por: Engel, Jörg B.
Publicado: (2015)

Cripto-1 in TNBC
por: Castro, Nadia P, et al.
Publicado: (2015)

IMMU-14. WAKING THE SLEEPING GIANT: TLR7/8 AGONIST TREATMENT STIMULATES TUMOR-ASSOCIATED MYELOID CELLS FOR MEDULLOBLASTOMA IMMUNOTHERAPY
por: Pauneto, Coral Alicea, et al.
Publicado: (2023)

Novel amphiphilic folic acid-cholesterol-chitosan micelles for paclitaxel delivery
por: Cheng, Li-Chun, et al.
Publicado: (2016)

Correction: Paclitaxel prodrug based mixed micelles for tumor-targeted chemotherapy
por: Tang, Dongyang, et al.
Publicado: (2020)

Molecular subtyping and functional validation of TTK, TPX2, UBE2C, and LRP8 in sensitivity of TNBC to paclitaxel
por: Elango, Ramesh, et al.
Publicado: (2021)

Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC)
por: Cordani, Nicoletta, et al.
Publicado: (2023)

Bioavailability Enhancement of Paclitaxel via a Novel Oral Drug Delivery System: Paclitaxel-Loaded Glycyrrhizic Acid Micelles
por: Yang, Fu-Heng, et al.
Publicado: (2015)

A biomimetic and pH-sensitive polymeric micelle as carrier for paclitaxel delivery
por: Ma, Boxuan, et al.
Publicado: (2018)

Sodium cholate-enhanced polymeric micelle system for tumor-targeting delivery of paclitaxel
por: Zhang, Xiaomin, et al.
Publicado: (2017)

Indomethacin-based stimuli-responsive micelles combined with paclitaxel to overcome multidrug resistance
por: Wang, Shuanghu, et al.
Publicado: (2017)

Dual functionalized hyaluronic acid micelles loading paclitaxel for the therapy of breast cancer
por: Liu, Zhanbiao, et al.
Publicado: (2023)

The Landscape of Targeted Therapies in TNBC
por: Vagia, Elena, et al.
Publicado: (2020)

HMGA1 positively regulates the microtubule-destabilizing protein stathmin promoting motility in TNBC cells and decreasing tumour sensitivity to paclitaxel
por: Sgubin, Michela, et al.
Publicado: (2022)

Dimethyl Fumarate Induces Apoptosis via Inhibition of NF-κB and Enhances the Effect of Paclitaxel and Adriamycin in Human TNBC Cells
por: Tsurushima, Katsumasa, et al.
Publicado: (2022)

Neural Functions Play Different Roles in Triple Negative Breast Cancer (TNBC) and non-TNBC
por: Tan, Renbo, et al.
Publicado: (2020)

New Advances in Biomedical Application of Polymeric Micelles
por: Figueiras, Ana, et al.
Publicado: (2022)

Enzyme Release from Polyion Complex by Extremely Low Frequency Magnetic Field
por: Vlasova, Kseniya Yu., et al.
Publicado: (2020)

The Evaluation of Cytotoxic Properties from CCB-2 Sugar Complexes Against TNBC and Non-TNBC Cells
por: Jenie, Riris Istighfari, et al.
Publicado: (2021)

PEG-Farnesyl Thiosalicylic Acid Telodendrimer Micelles as an Improved Formulation for Targeted Delivery of Paclitaxel
por: Zhang, Xiaolan, et al.
Publicado: (2014)

Polymeric Micelles Based on Modified Glycol Chitosan for Paclitaxel Delivery: Preparation, Characterization and Evaluation
por: Liang, Na, et al.
Publicado: (2018)

Co-Delivery of Paclitaxel and Doxorubicin by pH-Responsive Prodrug Micelles for Cancer Therapy
por: Jiang, Yanhua, et al.
Publicado: (2020)

A Multifunctional Polymeric Micelle for Targeted Delivery of Paclitaxel by the Inhibition of the P-Glycoprotein Transporters
por: Razzaq, Sobia, et al.
Publicado: (2021)

Improved oral absorption and anti-lung cancer activity of paclitaxel-loaded mixed micelles
por: Hou, Jian, et al.
Publicado: (2017)

Preparation and Release of pH-Sensitive β-Cyclodextrin Derivative Micelles Loaded with Paclitaxel
por: Zhao, Meirong, et al.
Publicado: (2022)

A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013
por: Ademuyiwa, Foluso O., et al.
Publicado: (2022)

Nitric oxide/paclitaxel micelles enhance anti-liver cancer effects and paclitaxel sensitivity by inducing ferroptosis, endoplasmic reticulum stress and pyroptosis
por: Li, Huilan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1kvq2n3f27isddkgsjdbreuhh7